Additionally, in the FOLFIRINOX group, the survival parameters were in favor of females compared to males (with OS 13.1 for women and 10.3 months for men, and PFS 7.2 for women and 5.9 months for men), but did not reach statistical significance [ 123 ].
← all excerpts
Sex-Related Differences in Pancreatic Ductal Adenocarcinoma Progression and Response to Therapy.
1
—
—